483
Natco Pharma LimitedNatco Pharma Limited – FDA 483, Feb 3, 2023
Record Details
An FDA inspection of NATCO Pharma Limited in Visakhapatnam, India, revealed two significant observations. The firm failed to document production and process control procedures at the time of performance, specifically regarding equipment cleaning logbooks. Additionally, investigations into unexplained discrepancies did not extend to other batches of the same drug product, particularly concerning retroactive assessment of impurity testing methods.
View Company Profile
ID · 5885a052-15bd-471a-bf42-a66c31c14e03
Other documents for Natco Pharma Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.